Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引:1
|
作者
Jamy, Omer [1 ]
Diebold, Kendall [1 ]
Davis, Kenneth [2 ]
Bachiashvili, Kimo [1 ]
Rangaraju, Sravanti [1 ]
Vachhani, Pankit [1 ]
Godby, Kelly N. [1 ]
Salzman, Donna [1 ]
Bhatia, Ravi [1 ]
机构
[1] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
关键词
D O I
10.1038/s41409-023-01977-7
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:823 / 825
页数:3
相关论文
共 50 条
  • [1] Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia
    Omer Jamy
    Kendall Diebold
    Kenneth Davis
    Kimo Bachiashvili
    Sravanti Rangaraju
    Pankit Vachhani
    Kelly N. Godby
    Donna Salzman
    Ravi Bhatia
    Bone Marrow Transplantation, 2023, 58 : 823 - 825
  • [2] Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53-Mutated Acute Myeloid Leukemia
    Jamy, Omer H.
    Diebold, Kendall
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Godby, Kelly N.
    Salzman, Donna
    Bhatia, Ravi
    BLOOD, 2022, 140 : 8959 - 8960
  • [3] Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
    Boddu, Prajwal
    Kantarjian, Hagop
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Andreeff, Michael
    Jabbour, Elias J.
    Benton, Christopher B.
    DiNardo, Courtney D.
    Konopleva, Marina
    Daver, Naval
    Patel, Keyur
    Takahashi, Koichi
    Kanagal-Shamanna, Rashmi
    Cortes, Jorge
    Kadia, Tapan
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2238 - 2241
  • [4] TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [5] Precision medicine for TP53-mutated acute myeloid leukemia
    Brattas, Marte Karen
    Reikvam, Hakon
    Tvedt, Tor Henrik Anderson
    Bruserud, Oystein
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (05): : 263 - 274
  • [6] Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?
    Shallis, Rory M.
    Bewersdorf, Jan P.
    Stahl, Maximilian F.
    Halene, Stephanie
    Zeidan, Amer M.
    CANCERS, 2022, 14 (10)
  • [7] Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia
    Vanttinen, Ida
    Ruokoranta, Tanja
    Saad, Joseph J.
    Kytola, Sari
    Hellesoy, Monica
    Gullaksen, Stein-Erik
    Ettala, Pia-Sofia
    Pyorala, Marja
    Rimpilainen, Johanna
    Siitonen, Timo
    Wennerberg, Krister
    Gjertsen, Bjorn T.
    Heckman, Caroline A.
    Kontro, Mika
    Kuusanmaki, Heikki
    BLOOD, 2023, 142
  • [8] Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments
    Granowicz, Eric M.
    Jonas, Brian A.
    ONCOTARGETS AND THERAPY, 2022, 15 : 423 - 436
  • [9] Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience*
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Gowda, Lohith
    Wei, Wei
    Hager, Karl
    Isufi, Iris
    Kim, Tae Kon
    Pillai, Manoj M.
    Seropian, Stuart
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Siddon, Alexa J.
    Zeidan, Amer M.
    LEUKEMIA & LYMPHOMA, 2020, 61 (09) : 2180 - 2190
  • [10] Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy
    Venugopal, Sangeetha
    Shoukier, Mahran
    Konopleva, Marina
    Dinardo, Courtney D.
    Ravandi, Farhad
    Short, Nicholas J.
    Andreeff, Michael
    Borthakur, Gautam
    Daver, Naval
    Pemmaraju, Naveen
    Sasaki, Koji
    Montalban-Bravo, Guillermo
    Marx, Kayleigh R.
    Pierce, Sherry
    Popat, Uday R.
    Shpall, Elizabeth J.
    Kanagal-Shamanna, Rashmi
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    CANCER, 2021, 127 (19) : 3541 - 3551